Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

@article{Kalil2013TreatmentOH,
  title={Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis},
  author={A. Kalil and M. Klompas and G. Haynatzki and M. Rupp},
  journal={BMJ Open},
  year={2013},
  volume={3}
}
  • A. Kalil, M. Klompas, +1 author M. Rupp
  • Published 2013
  • Medicine
  • BMJ Open
    • Objective Hospital-acquired pneumonia remains the most lethal and expensive nosocomial infection worldwide. Optimal therapy remains controversial. We aimed to compare mortality and clinical response outcomes in patients treated with either linezolid or vancomycin. Design Systematic review and meta-analysis. Data sources PubMed, EMBASE, Cochrane Library, American College of Physicians Journal Club, Evidence-based Medicine BMJ and abstracts from infectious diseases and critical care meetings were… CONTINUE READING
    View on Publisher
    bmjopen.bmj.com
    61 Citations
    Highly Influencial Citations
    1
    Background Citations
    13
    Results Citations
    6
    61 Citations
    Citation Type

    Citation Type

    Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis
    • 34
    Efficacy and safety of linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus (MRSA)-related pneumonia: updated systematic review and meta-analysis
    • Highly Influenced
    • PDF
    Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia.
    Linezolid versus vancomycin for nosocomial pneumonia due to methicillin‐resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly
    • 8
    Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus in Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital
    • 2
    • PDF
    Treatment of community-acquired pneumonia
    • 1
    New guidelines for nosocomial pneumonia
    • 11
    Proper use of antibiotics: situation of linezolid at the intensive care unit of the Tunisian Military Hospital
    • 2
    Risk of acute kidney injury in critically ill surgical patients with presumed pneumonia is not impacted by choice of methicillin-resistant staphylococcus aureus therapy
    • 1
    No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period
    • 9
    • PDF

    References

    SHOWING 1-10 OF 40 REFERENCES
    Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.
    • 82
    Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    • 431
    • PDF
    Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    • 603
    Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*
    • 103
    • PDF
    Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
    • 103
    • PDF
    Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    • 148
    • PDF
    Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    • 447
    • PDF
    Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    • 41
    Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children
    • 146
    Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
    • 246
    • PDF